Literature DB >> 23905127

Giant Sporadic Low Grade Malignant Peripheral Nerve Sheath (MPNST) of Left Thigh.

Dhiraj B Nikumbh1, K H Suryawanshi, N V Dravid, T B Patil, C M Rokade.   

Abstract

Malignant Peripheral Nerve Sheath Tumours (MPNST) are rare spindle- cell sarcomas which are derived from the schwann cells or the pleuripotent cells of the neural crest. MPNSTs are usually located in the peripheral nerve trunk roots, extremities and in the head and neck region. These tumours may arise as sporadic variants or in patients with neurofibromatosis1 (NF1). The estimated incidence of MPNSTs in the patients with NF1is 2-5% as compared to a 0.001% incidence in the general population. Herein, we are reporting a case of a giant sporadic (NF1 independent) low grade MPNST of the left thigh in 65 year female patient, which had a good prognosis.

Entities:  

Keywords:  Malignant Peripheral Nerve Sheet Tumour (MPNST); Neurofibromatosis 1 (NF1); Sporadic

Year:  2013        PMID: 23905127      PMCID: PMC3708222          DOI: 10.7860/JCDR/2013/5511.3082

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  12 in total

1.  Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases.

Authors:  R H Hruban; M H Shiu; R T Senie; J M Woodruff
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

2.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

Authors:  D G R Evans; M E Baser; J McGaughran; S Sharif; E Howard; A Moran
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

3.  High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization.

Authors:  Kiran K Mantripragada; Gillian Spurlock; Lan Kluwe; Nadia Chuzhanova; Rosalie E Ferner; Ian M Frayling; Jan P Dumanski; Abhijit Guha; Victor Mautner; Meena Upadhyaya
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

4.  Postradiation soft tissue sarcomas. An analysis of 53 cases.

Authors:  W B Laskin; T A Silverman; F M Enzinger
Journal:  Cancer       Date:  1988-12-01       Impact factor: 6.860

5.  Perineurial malignant peripheral nerve sheath tumor (MPNST): a clinicopathologic, immunohistochemical, and ultrastructural study of seven cases.

Authors:  T Hirose; B W Scheithauer; T Sano
Journal:  Am J Surg Pathol       Date:  1998-11       Impact factor: 6.394

6.  Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system.

Authors:  M Trojani; G Contesso; J M Coindre; J Rouesse; N B Bui; A de Mascarel; J F Goussot; M David; F Bonichon; C Lagarde
Journal:  Int J Cancer       Date:  1984-01-15       Impact factor: 7.396

7.  Survival data for patients with malignant schwannoma.

Authors:  David V Cashen; Robert C Parisien; Kevin Raskin; Francis J Hornicek; Mark C Gebhardt; Henry J Mankin
Journal:  Clin Orthop Relat Res       Date:  2004-09       Impact factor: 4.176

8.  Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues.

Authors:  Shyra J Miller; Fatima Rangwala; Jon Williams; Peter Ackerman; Sue Kong; Anil G Jegga; Sergio Kaiser; Bruce J Aronow; Silke Frahm; Lan Kluwe; Victor Mautner; Meena Upadhyaya; David Muir; Margaret Wallace; Jussara Hagen; Dawn E Quelle; Mark A Watson; Arie Perry; David H Gutmann; Nancy Ratner
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

9.  Malignant peripheral nerve sheath tumors (MPNST)--clinicopathological study and treatment outcome of twenty-four cases.

Authors:  Madhabananda Kar; S V Suryanarayana Deo; Nootan Kumar Shukla; Ajay Malik; Sidharth DattaGupta; Bidhu Kumar Mohanti; Sanjay Thulkar
Journal:  World J Surg Oncol       Date:  2006-08-22       Impact factor: 2.754

10.  Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.

Authors:  Pascale Lévy; Dominique Vidaud; Karen Leroy; Ingrid Laurendeau; Janine Wechsler; Giulia Bolasco; Béatrice Parfait; Pierre Wolkenstein; Michel Vidaud; Ivan Bièche
Journal:  Mol Cancer       Date:  2004-07-15       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.